Insider Selling: OneMedNet (NASDAQ:ONMD) CEO Sells 61,555 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green sold 61,555 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $1.20, for a total value of $73,866.00. Following the completion of the sale, the chief executive officer directly owned 1,804,103 shares of the company’s stock, valued at $2,164,923.60. This represents a 3.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Aaron Green also recently made the following trade(s):

• On Wednesday, October 22nd, Aaron Green sold 64,767 shares of OneMedNet stock. The stock was sold at an average price of $2.23, for a total transaction of $144,430.41.

OneMedNet Stock Performance

Shares of OneMedNet stock traded down $0.11 on Tuesday, reaching $1.29. 328,793 shares of the company were exchanged, compared to its average volume of 2,257,584. OneMedNet Corporation has a 1-year low of $0.30 and a 1-year high of $4.22. The company’s 50-day moving average is $1.73 and its two-hundred day moving average is $1.14. The firm has a market cap of $65.80 million, a price-to-earnings ratio of -25.80 and a beta of 1.10.

OneMedNet (NASDAQ:ONMD) last released its quarterly earnings data on Friday, November 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.18 million for the quarter.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Correct Capital Wealth Management purchased a new position in shares of OneMedNet during the third quarter worth approximately $4,910,000. Exencial Wealth Advisors LLC lifted its position in OneMedNet by 141.3% during the third quarter. Exencial Wealth Advisors LLC now owns 3,599,460 shares of the company’s stock valued at $3,923,000 after purchasing an additional 2,107,598 shares during the period. Finally, Ashton Thomas Private Wealth LLC purchased a new position in OneMedNet during the third quarter valued at approximately $25,000. 0.95% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Wall Street Zen upgraded OneMedNet to a “hold” rating in a report on Friday, September 26th. Weiss Ratings restated a “sell (d-)” rating on shares of OneMedNet in a research report on Tuesday, October 14th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.